Novacyt ownership
WebApr 9, 2024 · Novacyt delivered revenue for Q1 2024 of €83.0 million (£72.6 million). Approximately 50% of Q1 revenue was driven by sales to the DHSC, predominately PROmate™. WebNovacyt Ownership. Who are the major shareholders and have insiders been buying or selling? Recent Insider Transactions. OTCPK:NVYT.F; Recent Insider Transactions by Companies or IndividualsDate Value Name Entity Role Shares Max Price; 07 Jul 22: Buy US$9,830: James Wakefield: Individual: 7,000: US$1.40: 25 Mar 22: Buy US$132,520: …
Novacyt ownership
Did you know?
WebMar 16, 2024 · Novacyt S.A., together with its subsidiaries, engages in the development, manufacture, contract design, and commercialization of diagnostic products for cancer and infectious diseases in the United Kingdom, rest of Europe, the United States, the Asia Pacific, the Middle East, and Africa. WebNovacyt SA is engaged in developing and selling diagnostic products for cancer and infectious diseases. Its diagnostic products are used in LBC, oncology, microbiology, …
WebApr 12, 2024 · A high-level overview of Novacyt S.A. (NVYTF) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. WebMar 10, 2024 · The main competitors of Novacyt include C4X Discovery (C4XD), OKYO Pharma (OKYO), Tissue Regenix Group (TRX), Poolbeg Pharma (POLB), Ondine Biomedical (OBI), SkinBioTherapeutics (SBTX), Collagen Solutions plc (COS.L) (COS), 4D pharma (DDDD), Aptamer Group (APTA), and Oxford BioDynamics (OBD).
WebOct 1, 2024 · NOVACYT A French Société Anonyme. Registered office: 13 Avenue Morane Saulnier, 78140 V ÉLIZY-V ILLACOUBLAY. ... ownership or representation of the fraction of the capital required in accordance with the provisions of Article R. 225-71 of the French Commercial Code. A new certificate justifying the registration of the shares in the same ... WebMay 19, 2024 · View our latest analysis for Novacyt The Last 12 Months Of Insider Transactions At Novacyt In fact, the recent purchase by James Wakefield was the biggest …
WebNOVACYT has raised a total of $37.8M in funding over 7 rounds. Their latest funding was raised on May 30, 2024 from a Post-IPO Debt round. NOVACYT is registered under the ticker LSE:NCYT . NOVACYT is funded by 4 investors. Kreos Capital and YA Global Master SPV are the most recent investors. NOVACYT has acquired 4 organizations.
WebNovacyt SA (ALNOV) Stock Price & News - Google Finance Home ALNOV • EPA Novacyt SA Follow €0.62 Mar 17, 6:00:00 PM GMT+1 · EUR · EPA · Disclaimer search Compare to Poxel SA €0.72 POXEL1.38%... dianthus pharmaceuticalsWebApr 6, 2024 · Free-Float. 94,9%. More Financials. Company. Novacyt develops, produces, and sells in vitro and molecular diagnostic products for the microbiology, haematology and serology markets. The activity is organized around two sectors: - development of solutions and diagnostic services. The group is also developing a manufacturing activity for … dianthus petraeus ssp noeanusWebInsider Trading Novacyt S.A. Transaction Summary Total Insider Purchases and Sales Reported to the SEC Most Recent Insider Transactions July 2024 - July 2024 Filing Date … dianthus perennial or annualWebMar 22, 2024 · Novacyt SA is engaged in developing and selling diagnostic products for cancer and infectious diseases. Its diagnostic products are used in LBC, oncology, microbiology, hematology, and serology... dianthus pflegeWebNovacyt is a leading global diagnostics company. We protect people and society in the fight against infectious diseases by developing tests that accurately detect infections, allowing us to help safeguard people and … citibank direct armyNovacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying an extensive range assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare. citibank direct deposit bonusWebNovacyt S.A. (NCYT.L) LSE - LSE Delayed Price. Currency in GBp (0.01 GBP) Follow 54.65 +0.20 (+0.37%) At close: 04:06PM BST 1d 5d 1m 6m YTD 1y 5y Max Full screen Gain … citibank discharge authority